Abbott Laboratories (LON: 0Q15)

Abbott Laboratories Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 29, 2024	Dec 30, 2023	Dec 30, 2022	Dec 30, 2021	Dec 30, 2020	Dec 30, 2019
Cash & Equivalents	7,558	6,896	9,882	9,799	6,838	3,860
Short-Term Investments	230	383	288	450	310	280
Cash & Short-Term Investments	7,788	7,279	10,170	10,249	7,148	4,140
Cash Growth	10.52%	-28.43%	-0.77%	43.38%	72.66%	1.32%
Receivables	7,051	6,565	6,218	6,487	6,414	5,425
Inventory	6,813	6,570	6,173	5,157	5,012	4,316
Prepaid Expenses	2,049	2,087	2,251	2,054	1,777	1,638
Other Current Assets	101	169	412	292	90	148
Total Current Assets	23,802	22,670	25,224	24,239	20,441	15,667
Property, Plant & Equipment	10,621	11,276	10,278	10,112	10,130	8,972
Long-Term Investments	589	485	468	512	665	585
Goodwill	23,658	23,679	22,799	23,231	23,744	23,195
Other Intangible Assets	7,352	8,815	10,454	12,739	14,784	17,025
Long-Term Deferred Tax Assets	8,011	-	-	-	2,418	2,097
Other Long-Term Assets	323	6,289	5,215	4,363	366	346
Total Assets	74,356	73,214	74,438	75,196	72,548	67,887
Accounts Payable	4,034	4,295	4,607	4,408	3,946	3,252
Accrued Expenses	6,770	6,543	6,925	6,464	5,842	4,978
Short-Term Debt	-	-	-	-	213	201
Current Portion of Long-Term Debt	2,167	1,080	2,271	754	7	1,277
Current Portion of Leases	-	245	230	245	241	205
Current Income Taxes Payable	713	492	343	306	362	226
Other Current Liabilities	1,218	1,186	1,113	928	1,296	724
Total Current Liabilities	14,902	13,841	15,489	13,105	11,907	10,863
Long-Term Debt	12,879	13,599	14,522	17,296	18,527	16,661
Long-Term Leases	-	949	943	956	902	755
Long-Term Deferred Tax Liabilities	-	568	991	1,392	1,406	1,546
Other Long-Term Liabilities	-	3,466	3,804	3,685	3,684	3,944
Total Liabilities	34,328	34,387	37,533	39,172	39,545	36,586
Common Stock	25,020	24,869	24,709	24,470	24,145	23,853
Retained Earnings	39,056	37,554	35,257	31,528	27,627	25,847
Treasury Stock	-16,476	-15,981	-15,229	-11,822	-10,042	-10,147
Comprehensive Income & Other	-7,804	-7,839	-8,051	-8,374	-8,946	-8,465
Total Common Equity	39,796	38,603	36,686	35,802	32,784	31,088
Minority Interest	232	224	219	222	219	213
Shareholders' Equity	40,028	38,827	36,905	36,024	33,003	31,301
Total Liabilities & Equity	74,356	73,214	74,438	75,196	72,548	67,887
Total Debt	15,046	15,873	17,966	19,251	19,890	19,099
Net Cash (Debt)	-7,258	-8,594	-7,796	-9,002	-12,742	-14,959
Net Cash Per Share	-4.15	-4.91	-4.42	-5.03	-7.13	-8.40
Filing Date Shares Outstanding	1,734	1,735	1,738	1,763	1,772	1,763
Total Common Shares Outstanding	1,734	1,734	1,738	1,764	1,771	1,763
Working Capital	8,900	8,829	9,735	11,134	8,534	4,804
Book Value Per Share	22.94	22.26	21.11	20.29	18.51	17.64
Tangible Book Value	8,786	6,109	3,433	-168	-5,744	-9,132
Tangible Book Value Per Share	5.07	3.52	1.98	-0.10	-3.24	-5.18
Land	-	529	511	525	538	519
Buildings	-	4,161	4,053	4,007	4,014	3,702
Machinery	-	15,179	14,164	13,528	12,884	11,468
Construction In Progress	-	2,064	1,484	1,304	1,357	1,110

Source: S&P Capital IQ. Standard template. Financial Sources.